Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
09/2003
09/25/2003CA2478795A1 Use of rapamycin for inhibiting cell death
09/25/2003CA2478248A1 Methods and devices for detection and therapy of atheromatous plaque
09/25/2003CA2478172A1 Dihydroindol-2-one derivatives as steroid hormone nuclear receptor modulators
09/25/2003CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
09/24/2003EP1346730A1 Pretargeting methods and novel pretargeting conjugates
09/24/2003EP1346033A2 Novel serine protease genes related to dppiv
09/24/2003EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
09/24/2003EP1345946A1 Macroheterocylic compounds useful as kinase inhibitors
09/24/2003EP1345933A2 Process for making substituted 8-arylquinolinium benzenesulfonate
09/24/2003EP1345920A1 Novel sulfamides and their use as endothelin receptor antagonists
09/24/2003EP1345918A1 Chemical compounds
09/24/2003EP1345902A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
09/24/2003EP1345900A1 Guanidine and amidine derivatives as factor xa inhibitors
09/24/2003EP1345898A2 Teracyclic carbazole derivates and their use as spla2 inhibitors
09/24/2003EP1345856A2 Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same
09/24/2003EP1345694A2 A method for the manufacture of compositions containing low concentrations of salts
09/24/2003EP1345687A2 Cartridges useful in cleaning dialysis solutions
09/24/2003EP1345622A2 Eiav chimeric vaccine and diagnostic
09/24/2003EP1345619A2 Use of a composition for the stimulation of nerve growth, the inhibition of scar tissue formation, the reduction of secondary damage and/or the accumulation of macrophages
09/24/2003EP1345603A1 (halo-benzo carbonyl)heterocyclo fused phenyl p38 kinase inhibiting agents
09/24/2003EP1272489B1 Process for preparing crystalline form i of cabergoline
09/24/2003EP1259512B1 Pteridine compounds for the treatment of psoriasis
09/24/2003EP1224186B1 Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
09/24/2003EP1124554B1 Pharmaceutical compositions containing tetrahydroisoquinoline compounds
09/24/2003EP1123109B1 Contulakin-g, analogs thereof and uses therefor
09/24/2003EP1036061B1 New compounds
09/24/2003EP0984959B1 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds
09/24/2003EP0920430B1 Purine derivatives and their use as anti-coagulants
09/24/2003CN1444654A Novel therapeutic molecular variants and uses thereof
09/24/2003CN1444603A Low oxygen affinity mutant hemoglobins
09/24/2003CN1444597A 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
09/24/2003CN1444584A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamide inhibitors of cyclin dependent kinases
09/24/2003CN1444581A 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
09/24/2003CN1444573A Carboxamide compounds and their use as antagonists of human 11CBY receptor
09/24/2003CN1444571A Urethane derivatives
09/24/2003CN1444570A Non-steroidal inflammation inhibitors
09/24/2003CN1444567A 咪唑衍生物 Imidazole derivatives
09/24/2003CN1444566A Imidazolyl derivatives
09/24/2003CN1444561A Acetamide derivatives and use thereof as inhibitors of coagulation factors XA and VIIA
09/24/2003CN1444558A Novel N-(2-phenyl-3-aminopropyl) naphtamides
09/24/2003CN1444486A Use of interferon receptor 2c polypeptide chain to enhance anti-growth effects of type I interferons
09/24/2003CN1444477A Thrombopoietin mimetics
09/24/2003CN1444472A Plasmid DNA (Lipogenes TM) and nucleas-containing location signal/fusogene conjogates drug encapsulating into targeted liposomes complex
09/24/2003CN1443541A Ass hide glue ferrous oral liquor and its production method
09/24/2003CN1443536A Aspirin compound preparation for resisting inflammation, stopping pain and resisting thrombus
09/24/2003CN1122032C Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
09/24/2003CN1121875C Pharmaceutical compositions for freeze drying
09/23/2003US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents
09/23/2003US6624180 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade
09/23/2003US6624172 Imidazonaphthyridines
09/23/2003US6624167 Compounds that are capable of affecting nicotinic cholinergic receptors. A wide variety of conditions and disorders, and particularly conditions and disorders associated with dysfunction of the central and autonomic nervous systems can
09/23/2003US6624141 Protamine fragment compositions and methods of use
09/23/2003CA2129630C Method of increasing the concentration of nitric oxide in blood
09/23/2003CA2085781C Bradykinin-antagonists for the treatment of acute pancreatitis
09/18/2003WO2003076565A2 Methods of using 46828, a human acyl-coa synthetase
09/18/2003WO2003076461A2 Dimeric tf antagonist comprising two factor vii polypeptides
09/18/2003WO2003076458A2 Selective dipeptide inhibitors of kallikrein
09/18/2003WO2003076457A1 INHIBITORS OF THE BLOOD-CLOTTING FACTOR Xa, PRODUCTION THEREOF AND USE OF THE SAME
09/18/2003WO2003076447A1 An optically acitve pyridine derivative and a medicament containing the same
09/18/2003WO2003076432A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
09/18/2003WO2003076424A1 Macrocyclic compounds useful as pharmaceuticals
09/18/2003WO2003076407A1 Novel chalcone derivatives and uses thereof
09/18/2003WO2003076406A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003WO2003075923A1 Vdac regulator
09/18/2003WO2003075834A2 Activated protein c formulations
09/18/2003WO2003037363A3 Non-neurotoxic plasminogen activating factors for treating stroke
09/18/2003WO2003035861A3 Thrombin-cleavable chimeric proteins
09/18/2003WO2002092136A3 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
09/18/2003WO2002066646A3 Neurotransmission-associated proteins
09/18/2003WO2002059308A3 Method of diagnosing and treating cartilage disorders
09/18/2003US20030176853 Sustained release delivery systems for solutes
09/18/2003US20030176688 Expression systems utilizing autolyzing fusion proteins and a novel reducing polypeptide
09/18/2003US20030176686 Diagnosis, therapy; animal growth regulators; controlling cell differentiation; antiiinflammatory agents, antihistamines, Crohn's disease, anticancer agents, autoimmune disease
09/18/2003US20030176668 C-nitroso compounds and use thereof
09/18/2003US20030176650 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
09/18/2003US20030176511 Compositions and methods for treating cardiovascular disorders
09/18/2003US20030176509 Methods and products related to 16-HETE analogs
09/18/2003US20030176497 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/18/2003US20030176465 Cyclic amino acid derivatives
09/18/2003US20030176463 For therapy of disease states resulting from angiogenesis; can be administered orally
09/18/2003US20030176455 Inhibiting cell death following cellular regeneration in a mammal in need thereof, which comprises providing with an effective amount of a rapamycin
09/18/2003US20030176453 Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use therefor
09/18/2003US20030176445 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists
09/18/2003US20030176439 For therapy and prophylaxis of thromboembolic diseases and restenoses; reversible inhibitors of the blood clotting enzyme factor VIIa
09/18/2003US20030176405 8 Beta-hydrocarbyl-substituted estratrienes for use as selective estrogens
09/18/2003US20030176379 Useful in the administration of a drug, therapy
09/18/2003US20030176352 Peptides and related compounds having thrombopoietic activity
09/18/2003US20030176331 Having therapeutic, diagnostic, and preventative benefits, particularly as immunotoxins; for therapy of cancer
09/18/2003US20030176317 Stabilization of hypoxia inducible factor (HIF) alpha
09/18/2003US20030175969 Prevention infant blood disorders
09/18/2003US20030175775 Ligand for G-protein coupled receptor GPR43 and uses thereof
09/18/2003US20030175374 Oxidation resistance; anticancer agents, antiinflammatory agents; sunscreen agents
09/18/2003US20030175334 Phospholipid bodies and use thereof in medical treatment
09/18/2003US20030175327 Comprises crosslinked dextran-alginate spheres/beads on cotton gauze
09/18/2003US20030175238 Chemokine conjugates
09/18/2003CA2478942A1 An optically active pyridine derivative and a medicament containing the same
09/18/2003CA2478921A1 Novel chalcone derivatives and uses thereof
09/18/2003CA2478652A1 Nitrosodiphenylamine derivatives and their pharmaceutical use against oxidative stress pathologies
09/18/2003CA2478412A1 Inhibitors of the blood-clotting factor xa, production thereof and use of the same
09/18/2003CA2478065A1 Macrocyclic compounds useful as pharmaceuticals
1 ... 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 ... 671